Ulrich Duenzinger

Publications

Citations

H-Index

2013

Active since

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Ulrich Duenzinger is an author at The University of Texas MD Anderson Cancer Center specializing in cancer therapeutics, tumor microenvironment, and molecular pharmacology.

Top concepts

MedicineOncologyCell BiologyPharmacologyTumor BiologyCancer TherapyDrug DiscoveryPharmacotherapyDrug DevelopmentColorectal Cancer

Publications per year

2013–2021

Publications

Successful systemic high‐dose ribavirin treatment of respiratory syncytial virus‐induced infections occurring pre‐engraftment in allogeneic hematopoietic stem cell transplant recipients

Saskia Gueller, Ulrich Duenzinger, Timo Wolf et al. · Transplant Infectious Disease · 2013 · 43 citations

Abstract CT210: Trial in Process: Phase 1 studies of BI 1701963, a SOS1::KRAS Inhibitor, in combination with MEK inhibitors, irreversible KRASG12C inhibitors or irinotecan.

Marco H. Hofmann, Hengyu Lu, Ulrich Duenzinger et al. · Cancer Research · 2021 · 20 citations

Pharmacotherapy, Tumor Biology, Molecular Pharmacology +19

Early Disease Progression Predicts Poorer Survival in Patients with Follicular Lymphoma (FL) in the GALLIUM Study

Aino Launonen, Wolfgang Hiddemann, Ulrich Duenzinger et al. · Blood · 2017 · 14 citations

Rows per page

1–3 of 3